thromboembolic hospitalizations. A Kaplan-Meier survival curve was constructed to compare cumulative incidence of significant thromboembolic morbidity in the exposed and unexposed groups, and a Cox proportional hazards model, to control for confounders. RESULTS: During the study period 123,791 parturients met the inclusion criteria; 6.7% (n¼8,247) of which experienced previous RPL. The rate of thromboembolic related hospitalizations was significantly higher in exposed women as compared to non-exposed ones (1.1% vs. 0.6%, OR¼1.8; 95% 1.4-2.2; p<0.001). Cumulative thromboembolic event incidence, as depicted in the survival curves, was also significantly higher among patients with RPL history (Figure, Log rank p <0.001 ). The Cox model confirmed RPL history to be an independent risk factor for later maternal thromboembolic morbidity, while controlling for maternal age, ethnicity, and known thrombophilia (aHR 1.26, 95%CI 1.01-1.58, p¼0.040; Table) . CONCLUSION: A history of RPL is an independent risk factor for longterm thromboembolic morbidity, even in the absence of known maternal thrombophilia.
594 Perinatal palliative care experience and outcomes of journey to remember, a communitybased perinatal hospice program 
OBJECTIVE:
To describe the outcomes of pregnancies enrolled in a perinatal hospice program after prenatal diagnosis of a life limiting fetal condition. STUDY DESIGN: A retrospective analysis of a perinatal hospice program (PHP) established in 2012 was performed to assess the indications and outcomes of patient participants and to evaluate for any psychological benefits that positively impacted grief. RESULTS: During a 6 year period, 83 patients with a life limiting fetal condition were enrolled in the program, 12 of which did not follow up, 55 who received full support, 4 who received partial support, and 12 who received telephone support. The indications for enrollment were as follows: anencephaly (9), Trisomy 18 (31), Trisomy 13 (9), 45X (3), hydrops (2), polycystic kidneys/lower urinary tract obstruction (9), skeletal dysplasia (4), limb body wall complex (2), triploidy (2), congenital heart defects (3), and other indications (9). Eighteen patients were Spanish speaking only and 65 were English speaking. There were 29 fetal deaths and 36 live births. Data was not available for all participants. There were 51 vaginal deliveries, 7 primary cesarean sections, and 7 repeat cesarean sections. Twentyone patients delivered prematurely while 44 were born full term. Live born neonates died at an age ranging from less than 1 hour (6), 1-24 hours (14), 1-3 days (6), 4 days -1 month (0), 1-2 months (1), and 3-5 months (4). Twenty-four babies died in the hospital, and 7 were discharged and later died at home. There are 5 children who are still living. In year 6, a survey was sent to all parents. One-hundred percent of parents stated that PHP assisted them in coping with their experience. Reasons for their satisfaction were that they were able to discuss their worries and concerns, and received encouragement and support. When asked to rate their overall emotional health, responses included: poor 0%, fair 10%, good 31%, very good 31% and excellent 28%. All participants that responded said they would definitely recommend a PHP to others. CONCLUSION: A perinatal hospice program providing palliative care to parents carrying a fetus with life limiting conditions is a viable option to termination of pregnancy and has the potential of having tangible psychological benefits to these parents. OBJECTIVE: Failure to diagnosis of placenta accreta spectrum (PAS) prior to delivery is associated with worse outcomes. However, use of ultrasound and magnetic resonance imaging to diagnose placenta accreta spectrum (PAS) is costly and imprecise. We hypothesize that levels of specific cell-free miRNAs in the maternal blood will differ among women with PAS, placenta previa, and normal placentation. STUDY DESIGN: Women with suspected PAS, previa, or normal placentation were prospectively recruited at three academic centers in the UC fetal Consortium. PAS was confirmed by pathologic Poster Session III ajog.org evaluation. Maternal serum was collected, and total RNA was extracted, subjected to small RNA sequencing, and mapped to the miRBase human miRNA database. Groupwise differential expression analysis identified 13 candidate miRNAs, which were used to generate a support vector regression model for classification. The small RNA sequencing results for these candidate miRNAs were validated using qPCR. RESULTS: 60 women were recruited: 18 PAS, 15 placenta previa, and 27 normal placentation. The median gestational age at sample collection was 30w3d (IQR 28w -33w) and did not differ among groups (p¼0.13). The abundance of total miRNA reads as a percentage of all reads in the small RNA sequencing data was highest among women with PAS and lowest in normal placentation. Thirteen differentially expressed candidate miRNAs were identified (Figure 1 ). Support vector regression accurately classified samples into the three categories (Figure 2) . CONCLUSION: The percent total miRNA was significantly higher in maternal serum in cases of PAS compared to normal placentation. Thirteen candidate miRNAs were differentially expressed among groups and were used in a training model to accurately classify samples. Our results suggest that maternal serum miRNAs have the potential to serve as biomarkers for accurate antenatal diagnosis of PAS. Studies in a larger independent cohort are needed for validation of these results.
596 Factors that influence the maternal gut microbiome in early pregnancy The National Maternity Hospital, Dublin, Ireland OBJECTIVE: A mother's health before, during, and after pregnancy is crucial in determining the ultimate health outcome of the newborn. The maternal gut microbiome is thought to influence the colonization of the infant gut and thus, understanding the factors that affect it may provide an opportunity to optimize this crucial developmental step. STUDY DESIGN: One hundred and seventeen women were recruited in early pregnancy (16 weeksʼ gestation) as they presented for antenatal care in a tertiary level maternity unit, National Maternity Hospital, Dublin. Baseline demographic details were recorded from the health care record and antibiotic usage was self-reported. Microbial data were extracted from stool samples and subjected to metagenomic shotgun sequencing. Whole metagenome sequencing was performed on an Illumina NextSeq 500. Taxonomic profiling was performed using MetaPhlAn2 and all downstream analyses were performed in R using the vegan, psych and compareGroups packages. Pairwise Pearson correlations were performed and beta-diversity was calculated using Bray-Curtis dissimilarity and PCoA. Kruskal-Wallis was used to identify differentially abundant microbial species. P < 0.05 was considered significant following Benjimani-Hochberg FDR correction. RESULTS: The mean age of participants was 33 years and the mean body mass index (BMI) was 24.7kg/m 2 . 69 of the participants were nulliparous, while the remaining 48 had one or more children. 12 women reported antibiotic usage prior to 16 weeks gestation. A more diverse microbiome was seen in women who had one or more children (image 1) and a less diverse microbiome was seen in those with a BMI 30kg/m 2 (image 2), however these did not reach statistical significance. Antibiotic usage caused a decrease in Shannon and Simpson diversity but no overall change in the observed species. CONCLUSION: Although the number of pregnant women with obesity in our cohort is low, our results are in keeping with previous studies that indicate a less diverse microbiome in this population. Interestingly, the microbiome appears more diverse with increasing family size. This may be due to a more biodiverse environment with horizontal transfer of microbes among family members. This is important for future studies regarding the microbiome and gut health.
